文献速递消化道肿瘤与早癌

脂质组学结合靶向、单细胞和空间转录组学揭示结肠癌中未解决的促炎状态

Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer.
PubMed 文献 · Gut · 2025-03-06

研究对40例和81例人结直肠癌与正常配对样本分别进行非靶向和靶向定量脂质组学分析,整合转录组与空间转录组数据,发现肿瘤中促炎脂质介质失衡、促分解脂质介质(LXA4、LXB4)缺乏,提示脂质类别转换缺陷导致慢性炎症未解决。

要点

  • 结直肠癌肿瘤脂质组呈现促炎偏倚,促分解介质LXA4、LXB4及合成酶、受体表达不足。
  • 肿瘤中花生四烯酸衍生物及其合成酶、受体基因过表达,而促分解合成酶基因表达低下。
  • 作者认为结直肠癌是脂质类别转换缺陷的产物,可能与PGE2/PGD2水平不足或无效有关。

核心结论

  • 结直肠癌肿瘤脂质组显示明显的促炎偏倚,内源性促分解介质缺乏,继发于脂质类别转换缺陷。
  • 这些观察为「分解医学」铺平道路,即通过诱导或提供分解素来减轻驱动癌症生长和进展的慢性炎症。

研究设计与样本

  • 对40例人结直肠癌和正常配对样本进行液相色谱-串联质谱非靶向分析。
  • 对81例人结直肠癌和正常配对样本进行靶向定量分析。
  • 整合脂质组学、定量逆转录PCR、大规模基因表达和空间转录组学与公共单细胞RNA测序数据进行分析。

主要发现

  • 靶向定量LC-MS/MS显示促炎介质明显失衡,促分解脂质介质缺乏。
  • 肿瘤中观察到花生四烯酸衍生物、其合成酶和受体基因显著过表达。
  • 产生促分解合成酶的基因及 resultant 脂氧素(LXA4、LXB4)和相关受体表达不良。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Over a century ago, Virchow proposed that cancer represents a chronically inflamed, poorly healing wound. Normal wound healing is represented by a transitory phase of inflammation, followed by a pro-resolution phase, with prostaglandin (PGE2/PGD2)-induced 'lipid class switching' producing inflammation-quenching lipoxins (LXA4, LXB4). OBJECTIVE: We explored if lipid dysregulation in colorectal cancers (CRCs) is driven by a failure to resolve inflammation. DESIGN: We performed liquid chromatography and tandem mass spectrometry (LC-MS/MS) untargeted analysis of 40 human CRC and normal paired samples and targeted, quantitative analysis of 81 human CRC and normal paired samples. We integrated analysis of lipidomics, quantitative reverse transcription-PCR, large scale gene expression, and spatial transcriptomics with public scRNASEQ data to characterize pattern, expression and cellular localisation of genes that produce and modify lipid mediators. RESULTS: Targeted, quantitative LC-MS/MS demonstrated a marked imbalance of pro-inflammatory mediators, with a dearth of resolving lipid mediators. In tumours, we observed prominent over-expression of arachidonic acid derivatives, the genes encoding their synthetic enzymes and receptors, but poor expression of genes producing pro-resolving synthetic enzymes and resultant lipoxins (LXA4, LXB4) and associated receptors. These results indicate that CRC is the product of defective lipid class switching likely related to inadequate or ineffective levels of PGE2/PGD2. CONCLUSION: We show that the lipidomic profile of CRC tumours exhibits a distinct pro-inflammatory bias with a deficiency of endogenous resolving mediators secondary to defective lipid class switching. These observations pave the way for 'resolution medicine', a novel therapeutic approach for inducing or providing resolvins to mitigate the chronic inflammation driving cancer growth and progression.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Soundararajan R, Maurin MM, Rodriguez-Silva J, et al. Integration of lipidomics with targeted, single cell, and spatial transcriptomics defines an unresolved pro-inflammatory state in colon cancer. Gut. 2025. PMID: 39658263. doi:10.1136/gutjnl-2024-332535

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。